- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
IRF6 Antibody / Epithelial Development Transcription Factor Antibody recognizes interferon regulatory factor 6 (IRF6), a member of the interferon regulatory factor family of DNA-binding transcription factors. Unlike other IRF proteins that primarily regulate antiviral responses and interferon signaling, IRF6 functions predominantly in epithelial development, differentiation, and tissue morphogenesis. IRF6 is expressed in stratified epithelia and plays critical roles in the formation and maintenance of the skin, oral mucosa, and craniofacial structures. IRF6 Antibody / Epithelial Development Transcription Factor Antibody provides a valuable tool for investigating developmental pathways that govern epithelial homeostasis and tissue architecture.
IRF6 regulates the balance between cellular proliferation and differentiation through interactions with signaling pathways involving TP63, Notch, and epidermal growth factor receptors. Proper IRF6 activity is essential for keratinocyte maturation, epidermal barrier formation, and normal craniofacial development. In addition to its developmental functions, IRF6 contributes to wound healing and tissue repair by promoting epithelial migration and differentiation. IRF6 Antibody / Epithelial Development Transcription Factor Antibody is useful for studies of epithelial biology and mechanisms controlling tissue regeneration and morphogenesis.
Mutations in IRF6 are responsible for Van der Woude syndrome and popliteal pterygium syndrome, two inherited disorders characterized by cleft lip, cleft palate, and abnormalities of epithelial development. Defects in IRF6 signaling disrupt tissue fusion events during embryogenesis and impair epithelial differentiation. Animal models, including zebrafish and mice, have been instrumental in elucidating the molecular pathways controlled by IRF6. Emerging evidence also suggests that altered IRF6 expression may contribute to tumor progression and epithelial-mesenchymal transition in certain cancers. Consequently, IRF6 Antibody / Epithelial Development Transcription Factor Antibody has become increasingly important for developmental biology and disease research.
IRF6 Antibody / Epithelial Development Transcription Factor Antibody is widely used for investigations of craniofacial development, epidermal differentiation, wound healing, and congenital disorders affecting epithelial tissues. It supports studies of transcriptional regulation, tissue morphogenesis, and mechanisms underlying cleft lip and palate formation. IRF6 Antibody / Epithelial Development Transcription Factor Antibody provides a valuable reagent for examining normal epithelial biology and diseases associated with abnormal developmental signaling.
Learn more about proteins involved in nuclear signaling, transcriptional regulation, and developmental gene expression in our Transcription Factor Antibodies for Nuclear Signaling and Gene Regulation page.
Optimal dilution of the IRF6 Antibody / Epithelial Development Transcription Factor Antibody should be determined by the researcher.
Amino acids TPSMQLPPALPPQ were used as the immunogen for this IRF6 antibody. The sequence is common to isoforms 1 and 2.
Aliquot and store the IRF6 antibody at -20oC.
IRF6 antibody, Interferon Regulatory Factor 6 antibody, IRF-6 antibody, Developmental Transcription Factor antibody, Epithelial Differentiation Factor antibody, Cleft Lip and Palate Protein antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.